Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection with CEO Anne Wojcicki stepping down to help with a sale. And the U.S. Department of Health and Human Services (HHS)…
Read more...
Hence then, the article about cheaper wegovy 23andme shutters and rfk jr cuts fda jobs pharma news roundup was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup )
Also on site :
- CGTN: Why China's anti-corruption drive never stops
- Energy-as-a-Service: A Subscription Trap for Heavy Infrastructure
- Why Christmas Is Still a Diesel Stress Test for Energy Markets
